InflaRx NV’s Insider Sticking to the Course: No New Trades, But Options Keep the CEO’s Eyes on the Prize
Insider activity at InflaRx shows confidence but limited upside until milestones—see Mark Kubler’s vested options and 18 % weekly gains.
8 minutes to read